check_icon

Results with TREMFYA® in adults with active psoriatic arthritis

TREMFYA® CAN HELP REDUCE JOINT PAIN, STIFFNESS, AND SWELLING AT 24 WEEKS

In two medical studies, more than half of patients treated with TREMFYA® had at least a 20% improvement in active PsA symptoms (joint pain, stiffness, swelling) at 24 weeks compared to placebo.

FEWER PSORIATIC ARTHRITIS SYMPTOMS — MORE OF WHAT YOU USED TO DO

TREMFYA® can help reduce the joint pain, stiffness, and swelling that make everyday tasks harder to do. In two medical studies, patients’ ability to perform everyday activities was assessed in a questionnaire. At 24 weeks, people taking TREMFYA® showed an overall improvement in their ability to perform daily activities such as: 

action-icons-mobile

MORE THAN JOINT RELIEF — CLEARER SKIN, TOO

In two medical studies at 24 weeks, an improvement in psoriasis skin plaques was seen in psoriatic arthritis patients treated with TREMFYA®.

FATIGUE WAS REDUCED IN SOME PATIENTS

In two medical studies at 24 weeks, the level of fatigue was assessed using a questionnaire to measure self-reported tiredness, weakness, and difficulty conducting usual activities due to fatigue. Patients were asked to indicate their level of fatigue in the seven days prior.

Individual results may vary.

GET YOUR DOWNLOADABLE TREMFYA® BROCHURE

Ask your doctor about TREMFYA® and download the patient brochure to learn more.

TREMFYA® dosing

TREMFYA® is a 100 mg injection given under your skin at weeks 0 and 4, and then every 8 weeks. It is administered by a healthcare provider or self-injected only after proper training.

dosing mobile

Click below to learn about injection options and dosing with TREMFYA®.

TREMFYA® safety

SERIOUS AND COMMON SIDE EFFECTS WITH TREMFYA®

 

Ask your doctor about what you need to know before taking TREMFYA®, including potential risks. Prescription medications, including TREMFYA®, have possible risks involved with treatment, so it’s important to discuss them with your doctor.

TREMFYA® may cause serious side effects, including:

  • Serious allergic reactions. Stop using TREMFYA® and get emergency medical help right away if you develop any of the following symptoms of a serious allergic reaction:
    • fainting, dizziness, feeling lightheaded (low blood pressure)
    • swelling of your face, eyelids, lips, mouth, tongue or throat
    • trouble breathing or throat tightness
    • chest tightness
    • skin rash, hives
    • itching
  • Infections. TREMFYA® is a medicine that may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with TREMFYA® and may treat you for TB before you begin treatment with TREMFYA® if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with TREMFYA®.

Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:

  • fever, sweats, or chills
  • cough
  • shortness of breath
  • blood in your phlegm (mucus)
  • muscle aches
  • warm, red, or painful skin or sores on your body different from your psoriasis
  • weight loss
  • diarrhea or stomach pain
  • burning when you urinate or urinating more often than normal

These are not all the possible side effects of TREMFYA®.

Please read the Important Safety Information located at the bottom of the screen and the Medication Guide for TREMFYA® to learn more about these and other risks for TREMFYA®. Discuss any questions you have with your doctor.

The most common side effects of TREMFYA® include:

  • upper respiratory infections
  • joint pain (arthralgia)
  • fungal skin infections
  • headache
  • diarrhea
  • herpes simplex infections
  • injection site reactions
  • stomach flu (gastroenteritis)
  • bronchitis

These are not all the possible side effects of TREMFYA®. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.